Bal Pharma Ltd share price logo

Bal Pharma Ltd (BALPHARMA)

₹121.520.69%

bell
Get free price alerts. Set up your Free investment account to get Live Prices.
Overview
News
Financials
Q3 '23 Results
Technicals

Performance

  • Day's Low

    Day's High

    ₹120.71
    ₹124
  • 52 Week's Low

    52 Week's High

    ₹81.2
    ₹132.45
1 Month Return+ 1.23 %
3 Month Return+ 20.08 %
1 Year Return+ 29 %
Previous Close₹122.36
Open₹121.74
Volume31.07K
Upper Circuit-
Lower Circuit-
Market Cap₹193.38Cr

Key Statistics

P/E Ratio24.72
PEG Ratio7.56
Market Cap₹193.38 Cr
P/B Ratio1.09
EPS1.52

Company Information

BPL, a member of Macrolabs group, was incorporated in May 1987 and took over a pharmaceutical product manufacturing unit in Bangalore worth Rs 25.18 lac. The company manufactures and markets, pharmaceutical formulations such as paracetamol, aluminium hydroxide and povidone iodine. It came out with a public issue in Feb 1995 for the manufacturing of bulk drugs and expansion of pharmaceutical formulations. Additions to product range include AZIWIN CAFIMOL, CORTIDERM, Zanovid, Aziwin Dry Syrup, Meloxi Ocium, M Progit, MPS and Cardiac Specialities, AmilorideBenzydamine and Ebastine were added in 2002. BPL promotes its products through the sales force of the Macrolabs group and plans to launch its own soon. The unit has become a division of Bal Pharma Limited, thus marking an expansion in the drug production.

Share Price: ₹121.52 per share as on 11 Jul, 2024 04:01 PM
Market Capitalisation: ₹193.38Cr as of today
Revenue: ₹94.63Cr as on March 2024 (Q1 24)
Net Profit: ₹5.53Cr as on March 2024 (Q1 24)
Listing date: 08 May, 2006
OrganisationBal Pharma Ltd
HeadquartersBangalore
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Bal Pharma Ltd

  • Bal Pharma Ltd's Low P/E Ratio May Indicate Limited Growth Expectations - 30 May, 2024

    Investors may be expecting limited growth rates for Bal Pharma Ltd, resulting in a low P/E ratio of 25.5x. While the company has seen rapid earnings growth in the past year and three-year period, its medium-term trajectory is expected to lag behind the broader market's forecasted expansion.

  • Bal Pharma Q4 FY24 Net Profit Jumps to Rs 5.53 Crore - 29 May, 2024

    Bal Pharma's consolidated net profit for Q4 FY24 stood at Rs 5.53 crore, up from Rs 1.61 crore in Q4 FY23. The company's board has declared a dividend of Rs 1.20 per equity share. Bal Pharma stock locked in an upper circuit of 20%.

Insights on Bal Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, BALPHARMA stock has moved up by 2.0%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 81.76 Cr → 97.08 Cr (in ₹), with an average increase of 15.8% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 0.89 Cr → 5.47 Cr (in ₹), with an average increase of 83.7% per quarter

  • imgNO EFFECT

    FII Holding Unchanged

    img

    Foreign Institutions holdings remained unchanged at 0.13% of holdings in Mar 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 139.1% return, outperforming this stock by 114.0%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 51.23% of holdings in Mar 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Zydus Lifesciences Ltd has given 101.8% return, outperforming this stock by 72.8%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 48.64% of holdings in Mar 2024 quarter

Company Financials

Value in ₹ crore
Q'1 24Q/Q Change
Revenue
₹94.63Cr
↑15.88%
Net Income
₹5.53Cr
↑550.59%
Net Profit Margin
5.84%
↑461.54%
2023Y/Y Change
Revenue
₹304.22Cr
↑8.18%
Net Income
₹2.62Cr
↓54.04%
Net Profit Margin
0.86%
↓57.64%
Value in ₹ crore
2023Y/Y Change
Total Assets
₹350.43Cr
↑19.81%
Total Liabilities
₹254.40Cr
↑24.00%
Value in ₹ crore
2023Y/Y Change
Operating Cash Flow
₹5.07Cr
↓83.42%

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
51.23%
0.00
Foreign Institutions
0.13%
0.00
Mutual Funds
0%
0.00
Retail Investors
48.64%
0.00
Others
0%
0.00

Key Indicators

Bal Pharma Ltd Valuation

Bal Pharma Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-535.88x)

June 15, 2018

Today (24.72x)

July 10, 2024

Industry (62.76x)

July 10, 2024

Highest (203.65x)

September 12, 2018

LowHigh

Earnings and Dividends

  • Bal Pharma Ltd Earnings Results

    Bal Pharma Ltd’s net profit jumped 241.87% since last year same period to ₹5.47Cr in the Q4 2023-2024. On a quarterly growth basis, Bal Pharma Ltd has generated 514.61% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Bal Pharma Ltd Dividends May,2023

    In the quarter ending March 2023, Bal Pharma Ltd has declared dividend of ₹1 - translating a dividend yield of 1.63%.

    Read More about Dividends

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Bal Pharma Ltd is currently in a Bullish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Bal Pharma Ltd shares.

Bal Pharma Ltd (BALPHARMA) share price today is ₹121.52

Bal Pharma Ltd is listed on NSE

Bal Pharma Ltd is listed on BSE

  • Today’s highest price of Bal Pharma Ltd is ₹124.
  • Today’s lowest price of Bal Pharma Ltd is ₹120.71.

PE Ratio of Bal Pharma Ltd is 24.72

PE ratio = Bal Pharma Ltd Market price per share / Bal Pharma Ltd Earnings per share

Today’s traded volume of Bal Pharma Ltd(BALPHARMA) is 31.07K.

Today’s market capitalisation of Bal Pharma Ltd(BALPHARMA) is ₹193.38Cr.

Bal Pharma Ltd(BALPHARMAPrice
52 Week High
₹132.45
52 Week Low
₹81.2

Bal Pharma Ltd(BALPHARMA) share price is ₹121.52. It is down -8.25% from its 52 Week High price of ₹132.45

Bal Pharma Ltd(BALPHARMA) share price is ₹121.52. It is up 49.66% from its 52 Week Low price of ₹81.2

Bal Pharma Ltd(BALPHARMAReturns
1 Day Returns
-0.84%
1 Month Returns
1.23%
3 Month Returns
20.08%
1 Year Returns
29%